BioCentury
ARTICLE | Company News

PeptiDream, J&J deal

April 14, 2017 4:33 PM UTC

PeptiDream and Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit partnered to discover and optimize macrocyclic/constrained peptides against undisclosed metabolic and cardiovascular targets provided by Janssen using PeptiDream’s Peptide Discovery Platform System (PDPS) technology...